A.S. Raghunath
Helicobacter pylori Eradication in long-term Proton pump inhibitor Users in Primary care (HELPUP): a randomized controlled trial
Raghunath, A.S.; Hungin, A.P.S.; Mason, J.M.; Jackson, W.
Authors
A.P.S. Hungin
J.M. Mason
W. Jackson
Abstract
Background Two-thirds of proton pump inhibitor prescribing in the UK is for long-term therapy. Aim To determine the impact of eradication in long-term proton pump inhibitor users infected with Helicobacter pylori. Methods A total of 184 H. pylori-positive patients were randomly assigned to true or placebo eradication therapy. The primary outcome was the change in proton pump inhibitor usage measured by prescriptions; secondary outcomes were changes of proton pump inhibitor doses, dyspepsia symptoms, general practitioner consultations and quality of life measures. Results In the year following H. pylori eradication proton pump inhibitor prescriptions fell compared with placebo (−1.7, 95% CI: −2.3 to −1.1, P < 0.001); when adjusted to full-dose equivalent prescriptions the reduction was more marked (−2.2, 95% CI: −3.0 to −1.4, P < 0.001). Both general practitioner consultations (−1.0, 95% CI: −1.8 to −0.1, P = 0.026) and symptoms measured on the Leeds Dyspepsia Questionnaire (−3.1, 95% CI: −5.3 to −0.9, P = 0.005) were reduced. Quality of life and self-rating measures also favoured eradication (EQ-5D: 0.09, P = 0.08 and VAS: 5.6, P = 0.002). The Carlsson and Dent Reflux Questionnaire found no difference between groups (−0.3, P = 0.65), possibly balancing decreased overall symptoms with increased prominence of heartburn in the eradication group. Conclusions Helicobacter pylori eradication in infected, long-term proton pump inhibitor users in primary care reduced both the overall severity of symptoms and use of health care.
Citation
Raghunath, A., Hungin, A., Mason, J., & Jackson, W. (2007). Helicobacter pylori Eradication in long-term Proton pump inhibitor Users in Primary care (HELPUP): a randomized controlled trial. Alimentary Pharmacology and Therapeutics, 25(5), 585-592. https://doi.org/10.1111/j.1365-2036.2006.03234.x
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 14, 2006 |
Online Publication Date | Dec 21, 2006 |
Publication Date | Mar 1, 2007 |
Deposit Date | May 17, 2007 |
Journal | Alimentary Pharmacology and Therapeutics |
Print ISSN | 0269-2813 |
Electronic ISSN | 1365-2036 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 25 |
Issue | 5 |
Pages | 585-592 |
DOI | https://doi.org/10.1111/j.1365-2036.2006.03234.x |
You might also like
Transition from childhood to adulthood in coeliac disease: the Prague consensus report
(2016)
Journal Article
What calprotectin cut-offs should apply for IBD in general practice?
(2016)
Journal Article
Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome
(2016)
Journal Article
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search